Lebrikizumab reduces systemic inflammation in serum of patients with moderate-to-severe atopic dermatitis

被引：0
|
作者：
Guttman-Yassky, Emma [1 ]
Okragly, Angela [2 ]
Sun, Zhe [2 ]
Mena, Laura Rebeca [2 ]
Hahn, Nathan [2 ]
Nickoloff, Brian J. [2 ]
Siu, Kimberly [2 ]
Gallo, Gaia [2 ]
Wolf, Eric [2 ]
Eyerich, Kilian [3 ]
Aparici, Monica [4 ]
Benschop, Robert J. [2 ]
机构：
[1] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] Univ Freiburg, Med Ctr, Dept Dermatol, Freiburg, Germany
[4] Almirall SA, Barcelona, Spain
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 190卷
关键词：
atopic dermatitis; IL-13; lebrikizumab; placebo; serum biomarkers;
D O I：
10.1093/bjd/ljad498.006
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
495
引用
收藏
页码：II4 / II5
页数：2
相关论文
共 50 条
  • [1] Lebrikizumab reduces systemic inflammation in serum of patients with moderate-to-severe atopic dermatitis
    Guttman-Yassky, E.
    Okragly, A.
    Sun, Z.
    Mena, L. R.
    Hahn, N.
    Nickoloff, B. J.
    Siu, K.
    Gallo, G.
    Wolf, E.
    Eyerich, K.
    Aparici, M.
    Benschop, R. J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S364 - S364
  • [2] Lebrikizumab reduces systemic inflammation in serum of patients with moderate-to-severe atopic dermatitis
    Guttman-Yassky, E.
    Okragly, A.
    Sun, Z.
    Mena, L.
    Hahn, N.
    Nickoloff, B.
    Siu, K.
    Gallo, G.
    Wolf, E.
    Eyerich, K.
    Aparici, M.
    Benschop, R.
    EXPERIMENTAL DERMATOLOGY, 2024, 33 (03)
  • [3] Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
    Smith, Brandon I.
    Engel, Priya
    Wu, Jashin
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (24): : 2299 - 2300
  • [4] Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
    Diana Bernardo
    Thomas Bieber
    Tiago Torres
    American Journal of Clinical Dermatology, 2023, 24 : 753 - 764
  • [5] Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis
    Bernardo, Diana
    Bieber, Thomas
    Torres, Tiago
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (05) : 753 - 764
  • [6] LEBRIKIZUMAB MONOTHERAPY REDUCES FLARES IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
    Del Rosso, James Q.
    Kwong, Pearl
    Hussain, Iftikhar
    Barbarot, Sebastien
    Manuel Carrascosa, Jose
    Rueda, Maria Jose
    Atwater, Amber Reck
    Elmaraghy, Hany
    Sun, Luna
    Chen, Sherry
    Natalie, Chitra R.
    Weidinger, Stephan
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 32 - 32
  • [7] Improved and cleared facial and hand dermatitis with lebrikizumab in patients with moderate-to-severe atopic dermatitis
    Murase, Jenny E.
    Chovatiya, Raj
    Strowd, Lindsay
    Thyssen, Jacob P.
    Bangert, Christine
    Atwater, Amber Reck
    Gallo, Gaia
    Bardolet, Laia
    Yang, Fan
    Zhong, Jinglin
    Staumont-Salle, Delphine
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [8] Intriguing findings on lebrikizumab for treating moderate-to-severe atopic dermatitis
    Arents, Bernd W. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188 (06) : 694 - 694
  • [9] Efficacy and safety of lebrikizumab is maintained to two years in patients with moderate-to-severe atopic dermatitis
    Guttman-Yassky, Emma
    Weidinger, Stephan
    Simpson, Eric
    Gooderham, Melinda
    Irvine, Alan
    Spelman, Lynda
    Silverberg, Jonathan
    Elmaraghy, Hany
    DeLuca-Carter, Louise
    Piruzeli, Maria Lucia Buziqui
    Hu, Chaoran
    Yang, Fan Emily
    Pierce, Evangeline
    Bardolet, Laia
    Thaci, Diamant
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II3 - II4
  • [10] Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
    Silverberg, Jonathan I.
    Guttman-Yassky, Emma
    Thaci, Diamant
    Irvine, Alan D.
    Gold, Linda Stein
    Blauvelt, Andrew
    Simpson, Eric L.
    Chu, Chia-Yu
    Liu, Zhuqing
    Lima, Renata Gontijo
    Pillai, Sreekumar G.
    Seneschal, Julien
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (12): : 1080 - 1091
12345